SCHEMBL13662908

SCHEMBL13662908

CN(C)c1ccc(N=Nc2ccc(Cl)cc2O)c(O)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 13/20 0.56
RIOK2 Q9BVS4 1/20 0.49
TDP1 Q9NUW8 3/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
MEN1 O00255 1/20 0.40
NPC1 O15118 1/20 0.40
MAPT P10636 1/20 0.40
MAPK1 P28482 1/20 0.40
KMT2A Q03164 1/20 0.40
CASP3 P42574 1/20 0.40
SENP7 Q9BQF6 1/20 0.40
SENP6 Q9GZR1 1/20 0.40
ALDH1A1 P00352 2/20 0.39
CYP3A4 P08684 1/20 0.39
TSHR P16473 1/20 0.39
HSD17B10 Q99714 1/20 0.39
EGFR P00533 1/20 0.37
INSR P06213 1/20 0.37
POLB P06746 1/20 0.37
NSD2 O96028 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13662902 0.92 KCNH2 (0.52) KCNH2RIOK2TDP1L3MBTL1MEN1
SCHEMBL11759545 0.89 KCNH2 (0.66) KCNH2RIOK2TDP1MEN1MAPT
SCHEMBL11759552 0.89 KCNH2 (0.66) KCNH2RIOK2TDP1MEN1MAPT
SCHEMBL10604052 0.82 KCNH2 (0.64) KCNH2RIOK2MEN1MAPTKMT2A
SCHEMBL13662909 0.82 MAPT (0.45) KCNH2TDP1L3MBTL1MEN1NPC1
SCHEMBL11414575 0.78 KCNH2 (0.62) KCNH2RIOK2TDP1L3MBTL1MEN1
SCHEMBL11414578 0.78 KCNH2 (0.62) KCNH2RIOK2TDP1L3MBTL1MEN1
SCHEMBL13662912 0.77 NR1H2 (0.48) KCNH2TDP1L3MBTL1MEN1NPC1
SCHEMBL13662906 0.76 KCNH2 (0.52) KCNH2RIOK2TDP1MEN1NPC1
SCHEMBL20280048 0.76 KCNH2 (0.59) KCNH2RIOK2TDP1L3MBTL1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090269543-A1 OPTICAL RECORDING MEDIUM TDK CORPORATION (JP) 2009-10-29 US disclosed
US-20090269543-A1 OPTICAL RECORDING MEDIUM TDK CORPORATION (JP) 2009-10-29 US disclosed
US-20090226658-A1 Optical Recording Medium TDK CORPORATION (JP) 2009-09-10 US disclosed
US-20090226658-A1 Optical Recording Medium TDK CORPORATION (JP) 2009-09-10 US disclosed
US-20090149660-A1 OPTICAL RECORDING MATERIAL AND OPTICAL RECORDING MEDIA TDK CORPORATION (JP) 2009-06-11 US disclosed
US-20090149660-A1 OPTICAL RECORDING MATERIAL AND OPTICAL RECORDING MEDIA TDK CORPORATION (JP) 2009-06-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090149660-A1 OPTICAL RECORDING MATERIAL AND OPTICAL RECORDING MEDIA KCNN4, CACNA1E, KCNN2 KCNH2 6/4885RIOK2 1997/4885TDP1 3896/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.